-
Linagliptin, sold
under the
brand name
Tradjenta among others, is a
medication used to
treat type 2
diabetes (but not type 1) in
conjunction with exercise...
- Empagliflozin/
linagliptin, sold
under the
brand name Glyxambi, is a fixed-dose
combination anti-diabetic
medication used to
treat type 2 diabetes. It...
- (Kazano, Vipdomet).
Linagliptin combined with
metformin hydrochloride is sold
under the
brand name Jentadueto. As of
August 2021,
linagliptin/metformin is available...
- Empagliflozin/
linagliptin/metformin, sold
under the
brand name
Trijardy XR, is a fixed-dose
combination medication used for the
treatment of type 2 diabetes...
- the fixed-dose
combinations empagliflozin/
linagliptin, empagliflozin/metformin, and empagliflozin/
linagliptin/metformin. For
cardiovascular death, the...
-
Novartis as Galvus)
Saxagliptin (FDA
approved in 2009,
marketed as Onglyza)
Linagliptin (FDA
approved in 2011,
marketed as
Tradjenta by Eli
Lilly and Company...
- and
alogliptin A10BD10
Metformin and
saxagliptin A10BD11
Metformin and
linagliptin A10BD12
Pioglitazone and
sitagliptin A10BD13
Metformin and alogliptin...
- and dapagliflozin.
Another triple combination approval for metformin,
linagliptin, and
empagliflozin followed in 2020.
Diabetes medications have four main...
- Empagliflozin/
linagliptin Empagliflozin/metformin Gemigliptin/rosuvastatin
Glibenclamide (glyburide)/metformin Glimepiride/rosiglitazone
Linagliptin/metformin...
-
Giotrif (afatinib)
Jardiance (empagliflozin)
Jentadueto /
TrajentaDuo (
linagliptin / metformin)
Metalyse (tenecteplase)
Micardis (telmisartan) Micardis...
